Bristol Myers ' Opdivo-Yervoy Combo Meets Main Goal in Liver Cancer Trial Bristol Myers ' Opdivo-Yervoy Combo Meets Main Goal in Liver Cancer Trial

Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial treatment for a type of liver...Reuters Health Information
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Hematology-Oncology Source Type: news